Alimera Ebitda vs Ebit Analysis
ALIM Stock | USD 3.49 0.18 5.44% |
Alimera Sciences financial indicator trend analysis is way more than just evaluating Alimera Sciences prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Alimera Sciences is a good investment. Please check the relationship between Alimera Sciences Ebitda and its Ebit accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alimera Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Alimera Stock, please use our How to Invest in Alimera Sciences guide.
Ebitda vs Ebit
Ebitda vs Ebit Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Alimera Sciences Ebitda account and Ebit. At this time, the significance of the direction appears to have totally related.
The correlation between Alimera Sciences' Ebitda and Ebit is 0.99. Overlapping area represents the amount of variation of Ebitda that can explain the historical movement of Ebit in the same time period over historical financial statements of Alimera Sciences, assuming nothing else is changed. The correlation between historical values of Alimera Sciences' Ebitda and Ebit is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebitda of Alimera Sciences are associated (or correlated) with its Ebit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebit has no effect on the direction of Ebitda i.e., Alimera Sciences' Ebitda and Ebit go up and down completely randomly.
Correlation Coefficient | 0.99 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Ebitda
Ebit
Most indicators from Alimera Sciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Alimera Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alimera Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Alimera Stock, please use our How to Invest in Alimera Sciences guide.At this time, Alimera Sciences' Tax Provision is very stable compared to the past year. As of the 29th of April 2024, Issuance Of Capital Stock is likely to grow to about 85.1 M, while Sales General And Administrative To Revenue is likely to drop 0.22.
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 5.4M | 5.9M | 10.2M | 10.7M | Depreciation And Amortization | 2.6M | 2.7M | 8.7M | 9.2M |
Alimera Sciences fundamental ratios Correlations
Click cells to compare fundamentals
Alimera Sciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Alimera Sciences fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 50.3M | 50.9M | 58.5M | 42.6M | 153.5M | 161.2M | |
Short Long Term Debt Total | 39.0M | 44.6M | 43.6M | 44.3M | 67.4M | 70.8M | |
Other Current Liab | 4.7M | 3.2M | 3.4M | 4.0M | 12.8M | 13.5M | |
Total Current Liabilities | 12.0M | 12.3M | 12.6M | 39.7M | 21.9M | 14.3M | |
Total Stockholder Equity | (4.4M) | (8.0M) | (2.6M) | (20.8M) | 46.2M | 48.5M | |
Property Plant And Equipment Net | 2.0M | 2.4M | 4.5M | 3.9M | 3.6M | 3.8M | |
Net Debt | 29.6M | 33.4M | 27.1M | 39.1M | 55.3M | 58.1M | |
Retained Earnings | (387.6M) | (392.9M) | (397.3M) | (415.4M) | (418.5M) | (439.4M) | |
Accounts Payable | 7.1M | 7.5M | 8.7M | 10.1M | 8.3M | 5.0M | |
Cash | 9.4M | 11.2M | 16.5M | 5.3M | 12.1M | 19.3M | |
Non Current Assets Total | 17.6M | 15.9M | 16.4M | 13.2M | 101.1M | 106.2M | |
Non Currrent Assets Other | (16.8M) | (15.2M) | 833K | 183K | 52K | 54.6K | |
Cash And Short Term Investments | 9.4M | 11.2M | 16.5M | 5.3M | 12.1M | 20.5M | |
Net Receivables | 19.3M | 17.2M | 19.1M | 19.6M | 34.5M | 36.3M | |
Common Stock Total Equity | 691K | 701K | 50K | 57K | 65.6K | 62.3K | |
Common Stock Shares Outstanding | 4.8M | 5.1M | 6.6M | 7.0M | 25.6M | 26.8M | |
Liabilities And Stockholders Equity | 50.3M | 50.9M | 58.5M | 42.6M | 153.5M | 161.2M | |
Non Current Liabilities Total | 42.7M | 46.5M | 48.5M | 23.7M | 85.4M | 89.7M | |
Inventory | 1.4M | 2.7M | 2.7M | 1.6M | 1.9M | 1.7M | |
Other Current Assets | 2.6M | 3.7M | 3.8M | 2.9M | 3.9M | 2.5M | |
Other Stockholder Equity | 353.8M | 366.2M | 377.2M | 378.2M | 458.6M | 286.4M | |
Total Liab | 54.8M | 58.8M | 61.1M | 63.5M | 107.4M | 58.0M | |
Property Plant And Equipment Gross | 2.0M | 2.4M | 7.9M | 3.9M | 8.0M | 8.4M | |
Total Current Assets | 32.7M | 34.9M | 42.2M | 29.4M | 52.4M | 42.4M | |
Accumulated Other Comprehensive Income | (1.1M) | (553K) | (1.8M) | (3.0M) | 1.7M | 1.8M | |
Short Term Debt | 255K | 1.7M | 489K | 25.6M | 828K | 786.6K | |
Common Stock | 50K | 57K | 69K | 70K | 524K | 329.8K | |
Other Liab | 3.0M | 3.1M | 3.6M | 2.7M | 2.4M | 2.3M | |
Long Term Debt | 38.7M | 42.4M | 43.1M | 18.7M | 64.5M | 67.7M | |
Property Plant Equipment | 1.4M | 2.0M | 1.6M | 4.5M | 5.2M | 5.4M | |
Net Tangible Assets | (27.6M) | (49.5M) | (39.5M) | (29.1M) | (26.2M) | (27.5M) | |
Other Assets | 1.2M | 734K | 1.5M | 970K | 1.1M | 1.2M | |
Good Will | 18.7M | 16.7M | 14.8M | 12.8M | 14.8M | 14.4M | |
Retained Earnings Total Equity | (399.1M) | (377.1M) | (387.6M) | (392.9M) | (353.6M) | (371.3M) | |
Long Term Debt Total | 34.6M | 38.2M | 38.7M | 42.4M | 48.8M | 51.2M | |
Capital Surpluse | 341.6M | 346.1M | 350.1M | 365.8M | 420.7M | 335.8M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Alimera Sciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Alimera Sciences' short interest history, or implied volatility extrapolated from Alimera Sciences options trading.
Pair Trading with Alimera Sciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Alimera Sciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alimera Sciences will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Alimera Sciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Alimera Sciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Alimera Sciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Alimera Sciences to buy it.
The correlation of Alimera Sciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Alimera Sciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Alimera Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Alimera Sciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alimera Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Alimera Stock, please use our How to Invest in Alimera Sciences guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Complementary Tools for Alimera Stock analysis
When running Alimera Sciences' price analysis, check to measure Alimera Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alimera Sciences is operating at the current time. Most of Alimera Sciences' value examination focuses on studying past and present price action to predict the probability of Alimera Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alimera Sciences' price. Additionally, you may evaluate how the addition of Alimera Sciences to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
CEOs Directory Screen CEOs from public companies around the world | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |
Is Alimera Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alimera Sciences. If investors know Alimera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alimera Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.84) | Revenue Per Share 3.159 | Quarterly Revenue Growth 0.875 | Return On Assets (0.01) | Return On Equity (1.59) |
The market value of Alimera Sciences is measured differently than its book value, which is the value of Alimera that is recorded on the company's balance sheet. Investors also form their own opinion of Alimera Sciences' value that differs from its market value or its book value, called intrinsic value, which is Alimera Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alimera Sciences' market value can be influenced by many factors that don't directly affect Alimera Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alimera Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Alimera Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alimera Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.